speb/financial-data huggingface dataset:
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 7628000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 205582000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 462233000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1008215000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 205582000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1890923000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 168526000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 1336102000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2180000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 12907000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 15087000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 551707000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 23789000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 5069000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 5069000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 20547283.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 56.87
IRIS.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 1168524000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — EBIT: 21788000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — EBITDA: 26857000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 114377000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 99484000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 117109000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 825000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 825000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1903830000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 940658000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 5448000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 0.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 5448000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 53868000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 175000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 20000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Income: 1168524000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 1168524000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 18388000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: -209751000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Income Extraordinary: 1359867000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -191343000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 18408000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 1168504000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -825000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -825000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 99484000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1776546000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 11500000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 0.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 26857000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 18408000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Operating Income: -3576000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 285635000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 20558247.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 66409000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 185013000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 1685341000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 114377000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 25364000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 115616000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 99484000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 590000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 545982000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Payables: 138123000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 20963000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 168526000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5069000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 20558247.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1890923000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1776546000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 2575000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.12
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 0.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 2502121000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1890923000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 20535000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1891098000.00
IRIS.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 289211000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 611023000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1166019000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 59316000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 111595000.00
IRIS.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 784395000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 131306000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 355883000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 20593411.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 2.58
IRIS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 179190000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 5373000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 5373000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 20754297.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.56
IRIS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 53131000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — EBIT: 73453000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 78826000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 176693000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 2113000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 2113000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -5000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Income: 53131000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 53131000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 53136000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Income Extraordinary: 0.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 53131000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 53131000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 53136000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -2113000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -2113000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 78826000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 53131000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 45387000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 355883000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 28066000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 125933000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 71340000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 179190000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5373000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 18204000.00
IRIS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
IRIS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 310496000.00
IRIS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 577900000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 156408000.00
IRIS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 1285000000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 391545000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 30400000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 30400000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 274900000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 274900000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -83400000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -83400000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 328500000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 328500000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -14300000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -14300000.00
IRIS.NS income_statement (annual, 2026-03-31) — Amortization: 13600000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 9400000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 491200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 491200000.00
IRIS.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 20600000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 20537624.00
IRIS.NS income_statement (annual, 2026-03-31) — Basic EPS: 6.89
IRIS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.02
IRIS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 304700000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 107100000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 107100000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -84300000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 6600000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 6600000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 205700000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 205700000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 133200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 133200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1029700000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1029700000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 60200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 60200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 73000000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 73000000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -125200000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 93900000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Change In Payable: -500000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -5800000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -42200000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -171500000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 205700000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 205700000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 2007300000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2007300000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 3000000.00
IRIS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 613100000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 186925000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 1625000000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1625000000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 2400000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 2400000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Current Debt: 10000000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 10000000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 12400000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 12400000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Current Deferred Assets: 1600000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 1600000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 461200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 461200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 26000000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 26000000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 265800000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Depreciation: 11400000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 20800000.00
IRIS.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 20800000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 5400000.00
IRIS.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 7200000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 5400000.00
IRIS.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 20800000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 20743000.00
IRIS.NS income_statement (annual, 2026-03-31) — Diluted EPS: 6.82
IRIS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.00
IRIS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 1265000000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 41486000.00
IRIS.NS income_statement (annual, 2026-03-31) — EBIT: 173500000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — EBIT: 72667000.00
IRIS.NS income_statement (annual, 2026-03-31) — EBITDA: 194300000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 78067000.00
IRIS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 133200000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -29100000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 966300000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -22500000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: -1439600000.00
IRIS.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 84400000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 143300000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 143300000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 289200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 289200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 182000000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 182000000.00
IRIS.NS income_statement (annual, 2026-03-31) — Gross Profit: 671900000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 204620000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 0.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 0.00
IRIS.NS income_statement (annual, 2026-03-31) — Interest Expense: 1800000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 1103000.00
IRIS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1800000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 1103000.00
IRIS.NS income_statement (annual, 2026-03-31) — Interest Income: 45900000.00
IRIS.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 45900000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -1400000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 13900000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 2017300000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2017300000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1193000000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 491200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 491200000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 3000000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 4200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 4200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 0.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 0.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 4200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 54403000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 54403000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 74900000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 74900000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 100000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 100000.00
IRIS.NS income_statement (annual, 2026-03-31) — Minority Interests: -400000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -6000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 3000000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 3800000.00
IRIS.NS income_statement (annual, 2026-03-31) — Net Income: 1265000000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Net Income: 41486000.00
IRIS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 1265000000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 41486000.00
IRIS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 141600000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 66426000.00
IRIS.NS income_statement (annual, 2026-03-31) — Net Income Discontinuous Operations: -236100000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: -24934000.00
IRIS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1265000000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 41486000.00
IRIS.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1501100000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 66420000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 1265400000.00
IRIS.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 1265400000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 41492000.00
IRIS.NS income_statement (annual, 2026-03-31) — Net Interest Income: 40300000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -1103000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1122600000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -28000000.00
IRIS.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: 40300000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -1103000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Net PPE: 98600000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 98600000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -84300000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -28000000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 1864000000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1864000000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Assets: 145200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 145200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 11500000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 11500000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 54400000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 54400000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 12200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 12200000.00
IRIS.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: -1164100000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 78067000.00
IRIS.NS income_statement (annual, 2026-03-31) — Normalized Income: 380835352.36
IRIS.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 66420000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1050600000.00
IRIS.NS income_statement (annual, 2026-03-31) — Operating Income: 94000000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Operating Income: 48212000.00
IRIS.NS income_statement (annual, 2026-03-31) — Operating Revenue: 1285000000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 391545000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 20568247.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 20568247.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 65588000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 65588000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 155988000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 155988000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 41800000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 41800000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 143300000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 143300000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -39300000.00
IRIS.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 43600000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 24455000.00
IRIS.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 363600000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 151008000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Other Payable: 23200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 23200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Other Properties: 98567000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 98567000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 257500000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 257500000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 896500000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 896500000.00
IRIS.NS income_statement (annual, 2026-03-31) — Other Special Charges: -1359000000.00
IRIS.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Payables: 59600000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Payables: 59600000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 26100000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 26100000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 17800000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 17800000.00
IRIS.NS income_statement (annual, 2026-03-31) — Pretax Income: 171700000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 71564000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
IRIS.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 0.00
IRIS.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1568400000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -84300000.00
IRIS.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 613100000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 186925000.00
IRIS.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 20800000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 5400000.00
IRIS.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 6100000.00
IRIS.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 6100000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 23000000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 23000000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 1455100000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1455100000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 445800000.00
IRIS.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 27100000.00
IRIS.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 111500000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Share Issued: 20568247.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 20568247.00
IRIS.NS income_statement (annual, 2026-03-31) — Special Income Charges: 1358400000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 27400000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 2007300000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2007300000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 1864000000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1864000000.00
IRIS.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 238135352.36
IRIS.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IRIS.NS income_statement (annual, 2026-03-31) — Tax Provision: 30100000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 5138000.00
IRIS.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.18
IRIS.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.07
IRIS.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 20500000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 20500000.00
IRIS.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -268100000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Total Assets: 2527200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 2527200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 2007300000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2007300000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Total Debt: 16600000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 16600000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 2007400000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2007400000.00
IRIS.NS income_statement (annual, 2026-03-31) — Total Expenses: 1191000000.00
IRIS.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 343333000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 519800000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 519800000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 902200000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 902200000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 58600000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 58600000.00
IRIS.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 3800000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 6000000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 6000000.00
IRIS.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 1358400000.00
IRIS.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 1358400000.00
IRIS.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1163800000.00
IRIS.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1163800000.00
IRIS.NS income_statement (annual, 2026-03-31) — Write Off: 600000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -241759000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 1292000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Amortization: 9691000.00
IRISDOREME.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 9691000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 10502000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 170677091.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Basic EPS: 0.59
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 185130000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 405000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 170677091.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Diluted EPS: 0.59
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 184796000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 6505000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Interest Income: 869000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 869000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 10502000.00
IRISDOREME.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 51623000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1835000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 339308000.00
IRISDOREME.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: 0.00
IRISDOREME.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -1000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 10502000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 170678409.00
IRISDOREME.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: -1000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Other Payable: 5461000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Other Special Charges: -68000.00
IRISDOREME.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: -2767000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 19704000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 40482000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 3288000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 3288000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 13806000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 322474000.00
IRISDOREME.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 768000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 11523000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 18028000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Share Issued: 170678409.00
IRISDOREME.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 51623000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 627000.00
IRISDOREME.NS balance_sheet (annual, 2022-03-31) — Work In Process: 112152000.00
IRISDOREME.NS income_statement (annual, 2022-03-31) — Write Off: -33000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — +Operating Expense: 326126000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — +Total Revenue: 1125699000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 167223000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 312522000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -294482000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 1292000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Amortization: 9531000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 9531000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 11003000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 170678409.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Basic EPS: 0.48
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 405000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 185130000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -10459000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 66162000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 163141000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 178000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 178000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 178000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -111774000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Change In Payable: 51145000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -78478000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -139107000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -227000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Common Stock: 163141000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 569497000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 0.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 659130000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Current Assets: 804458000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 7906000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Current Debt: 284828000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 292734000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 465335000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Depreciation: 43496000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 53027000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 53027000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 43496000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 170678409.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Diluted EPS: 0.48
IRISDOREME.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 82589000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — EBIT: 141200000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — EBITDA: 194227000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — End Cash Position: 178000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -6836000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 280820000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 6443000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 6487000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 245000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 563336000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Gross Profit: 466569000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Interest Expense: 29153000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 29153000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Interest Income: 903000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 903000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -23053000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 903000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Inventory: 449204000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 854325000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -10293000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 11003000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 29817000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 1835000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 58256000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 58256000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 349453000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Net Debt: 284650000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Net Income: 82589000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 82589000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 82589000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: 0.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 82589000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 82589000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 112047000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 82589000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Net Interest Income: -29077000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -737000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 29817000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -29077000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -1000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Net PPE: 268854000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -10459000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 29817000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 569252000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 8529000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 11003000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 194074000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Normalized Income: 82478335.10
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 16902000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Operating Income: 140443000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Operating Revenue: 1125699000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 170678409.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 22462000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 468000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 406356000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 245000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 29078000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -1000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 1000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 12000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 68360000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Payable: -39000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Properties: 26918000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 423000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 14543000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Other Special Charges: -153000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Payables: 171337000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 0.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 22462000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Pretax Income: 112047000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -10459000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 49379000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 659130000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 53027000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 3627000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 3627000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 14543000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 405064000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 16269000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 22756000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Share Issued: 170678409.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 29817000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Special Income Charges: 153000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 569497000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 569252000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 42335.10
IRISDOREME.NS income_statement (annual, 2023-03-31) — Tax Provision: 29458000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.28
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 5126000.00
IRISDOREME.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -38146000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Total Assets: 1093088000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 569497000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Total Debt: 350990000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 569497000.00
IRISDOREME.NS income_statement (annual, 2023-03-31) — Total Expenses: 985256000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 523591000.00
IRISDOREME.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 288630000.00